Patients with previous diagnosis of iliac vein thrombosis are enrolled in this registry. Using standardized questionnaire, clinical data detailing venous thromboembolism and contributing VTE risk factors are recorded. Results of technical and laboratory investigations including screening of thrombophilic disorders were additionally entered into the database.
Study Type
OBSERVATIONAL
Enrollment
85
genetic Evaluation of Factor-V-Leiden, Factor-II\_G20210A Mutation;
Cardioangiologisches Centrum Bethanien
Frankfurt am Main, Hesse, Germany
Incidence and severity of postthrombotic Syndrome after iliofemoral thrombosis
The incidence and severity of postthrombotic Syndrome will be measured by te VILALLTA-Score
Time frame: up to 20 years after occurrence of iliofemoral thrombosis
Distribution of gender in Iliofemoral thrombosis
Distribution of gender (man or woman)
Time frame: since 1996
Distribution of affected side in Iliofemoral thrombosis
distribution of affected side (left or right side)
Time frame: since 1996
Disease-specific quality of life instrument for use in venous diseases of the leg (VEINES-QOL)
A quality of life questionaire comprises 25 items that quantify disease effect on quality of life
Time frame: 1 year
Incidence of venous claudication
Walking distance on treadmill
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.